PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Center for Convergent Research of Emerging Virus Infection (CEVI), Korea Research Institute of Chemical Technology, 141 Gajeong-ro, Yuseong-gu, Daejeon 34114, South Korea.\', \'Zoonotic Virus Laboratory, Institut Pasteur Korea, Seongnam-si, Gyeonggi-do 13488, South Korea.\', \'Herbal Medicine Research Division, Korea Institute of Oriental Medicine, Daejeon 34054, South Korea.\', \'KM Application Center, Korea Institute of Oriental Medicine, Dong-gu, Daegu 41062, South Korea.\', \'Department of Non-Clinical Studies, Korea Institute of Toxicology, Yuseong-gu, Daejeon 34114, South Korea.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0960-894X(20)30778-210.1016/j.bmcl.2020.127667
?:hasPublicationType
?:journal
  • Bioorganic & medicinal chemistry letters
is ?:pmid of
?:pmid
?:pmid
  • 33160024
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Discovery of cyclic sulfonamide derivatives as potent inhibitors of SARS-CoV-2.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all